Organigram Global Inc. (OGI) stock

OGINasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 40-F on Dec 16, 2025Score 4/30

$0.83−0.01 (-0.65%)

Close on Nov 13, 2026Market cap $111.41MP/E –Yield –

Organigram Global profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Organigram Global has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Organigram Global's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-4 reverse split on Dec 19, 2023
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is OGI.

Revenue growth77.8% · median 10.7%

Gross margin34.8% · median 35.9%

Operating margin-5.9% · median 1.3%

Advertisement
300 × 250

See a number that looks wrong?